Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

MicroRNA markers for discriminating metastatic and non-metastatic squamous cell lung carcinoma

A non-metastatic, lung squamous cell carcinoma technology, applied in the direction of DNA / RNA fragments, recombinant DNA technology, the use of vectors to introduce foreign genetic material, etc., can solve the problem that the role cannot be underestimated

Inactive Publication Date: 2014-07-30
SHANGHAI INST OF ONCOLOGY
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Although the proportion of microRNA in the total RNA of cells is very small, because it can efficiently regulate all mRNAs with target sites, the role of microRNA in the development of organisms and even the occurrence and development of tumors is still important. Not to be underestimated

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • MicroRNA markers for discriminating metastatic and non-metastatic squamous cell lung carcinoma
  • MicroRNA markers for discriminating metastatic and non-metastatic squamous cell lung carcinoma
  • MicroRNA markers for discriminating metastatic and non-metastatic squamous cell lung carcinoma

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0075] The preparation of the miRNA chip can adopt conventional manufacturing methods of biochips known in the art. For example, if the solid phase carrier is a modified glass slide or silicon wafer, and the 5' end of the probe contains amino-modified poly dT strings, the oligonucleotide probe can be formulated into a solution, and then spotted with a spotting instrument. The miRNA chip of the present invention can be obtained by arranging in a predetermined sequence or array on a modified glass slide or a silicon chip, and then fixing it by standing overnight. If the nucleic acid does not contain amino modification, its preparation method can also refer to: "Gene Diagnosis Technology-Non-radioactive Operation Manual" edited by Wang Shenwu; J.L.erisi, V.R.Iyer, P.O.BROWN. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science, 1997; 278: 680 and Ma Liren, edited by Jiang Zhonghua. Biochip. Beijing: Chemical Industry Press, 2000, 1-130.

[0...

Embodiment 1

[0094] The preparation of embodiment 1RNA sample

[0095] 1. Tissue samples:

[0096] 46 pairs of metastatic and non-metastatic samples (21 metastatic, 25 non-metastatic) were obtained from surgical resection specimens of lung squamous cell carcinoma patients, and these specimens were obtained from Shanghai Chest Hospital. All the above-mentioned specimens were obtained with the approval of the ethics committee of the WHO partner organization authorized by the Shanghai Municipal Government. The clinical data of tissue samples include: gender, age, tumor size, pathological grade (TNM stage), metastasis or not, etc.

[0097] 2. Gene chip:

[0098] microRNA expression profiling chip, using the crystal core of Boao Biotechnology Co., Ltd. Expression profiling chip (single-channel chip).

[0099] 3. Extraction of total tissue RNA

[0100] 3.1 Collection and storage of samples: The isolated tissues were cut into small pieces and immediately frozen in liquid nitrogen, and then ...

Embodiment 2

[0104] Extraction and labeling of embodiment 2microRNA

[0105] The miRNAs were extracted with Ambion's miRNAs extraction kit, and the specific operations were performed according to the corresponding instructions. Samples were labeled with T4 RNA ligase according to Thomson's method. In short, here's how:

[0106] 1.4 μg miRNA and 500ng 5′-phosphate-cytosine-uracil-cy3-3′ (Dharmacon, Chicago, USA) and 2 units of T4 RNA ligase (NEB, Ipswich, USA) were incubated at 4°C for 2 hours. miRNAs are labeled. An equal amount of corresponding negative control was set up for each miRNA sample.

[0107] 2. The labeled RNA was precipitated with 0.3M sodium acetate and 2.5 volumes of ethanol, and then resuspended with 15 μl of hybridization solution containing 3×SSC, 0.2% SDS and 15% formamide. All hybridizations were repeated twice, and the hybridization was performed with LifterSlip TM (Erie, PAUSA) to ensure that the hybridization solution flows evenly between the chip and the covers...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to 21 microRNA markers for discriminating metastatic and non-metastatic squamous cell lung carcinoma. More specifically, the invention relates to a class of microRNA markers for discriminating metastatic and non-metastatic squamous cell lung carcinoma. It has been proved by examination that, the specific microRNA markers can effectively discriminate metastatic and non-metastatic squamous cell lung carcinoma tissue. The invention also relates to a chip and a test kit for detecting the microRNA markers.

Description

technical field [0001] The present invention relates to the field of biotechnology, and more specifically, the present invention relates to a class of microRNA markers that can be used to distinguish metastatic and non-metastatic lung squamous cell carcinoma tissues and its application. The invention also relates to a chip and a kit for detecting the microRNA marker. Background technique [0002] Primary squamous cell carcinoma of the lung is one of the most common malignant tumors in my country. It is highly malignant, develops rapidly, is difficult to treat, and has a high mortality rate. Therefore, the early diagnosis of squamous cell carcinoma of the lung becomes more and more urgent. [0003] The occurrence and development of anything is under the joint action of internal and external factors, internal factors are dominant, and external factors are supplementary. As the genetic medium of life, genes are the basic internal causes in the birth, aging, disease and death ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/113C12N15/63C12Q1/68C40B40/06
Inventor 何祥火梁琳慧陆舜陈智伟虞永峰
Owner SHANGHAI INST OF ONCOLOGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com